BKV insider plans Rule 144 sale of 22,669 shares via Schwab on NYSE
BKV Corp received a Form 144 notice from a shareholder to sell up to 22,669 common shares under Rule 144.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
BKV Corp received a Form 144 notice from a shareholder to sell up to 22,669 common shares under Rule 144. The filing lists an approximate sale date of 11/05/2025, with an aggregate market value of $566,738. The designated broker is Charles Schwab & Co., Inc., and the shares are to be sold on the NYSE.
The shares were originally acquired on 05/01/2020 as Founders Shares. Recent activity by the same filer over the past three months includes sales of 10,000 shares on 08/12/2025 for $216,200 and 9,187 shares on 09/02/2025 for $212,984, among other transactions.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did BKV (BKV) disclose in this filing?
A shareholder filed Form 144 to sell up to 22,669 BKV common shares under Rule 144.
What is the aggregate market value of the planned sale?
The filing states an aggregate market value of $566,738 for the 22,669 shares.
Which broker and exchange are listed for the sale?
Charles Schwab & Co., Inc. is the broker, and the shares are to be sold on the NYSE.
AI-generated analysis. How Rhea-AI works. Not financial advice.